Background illustration for clinical trials search

Paid Clinical Trials Norfolk

Discover 379 paid clinical trials in Norfolk, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Norfolk VA, Durham NC, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07493512

Phase 1, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Norfolk VA, Fairfax VA, Rockville MD, Myrtle Beach SC,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase 3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Norfolk VA, Raleigh NC, Fairfax VA, Washington D.C. DC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase 1, Phase 2, Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Norfolk VA, Raleigh NC, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase 3, Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Norfolk VA, Newark DE, Christiansburg VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Norfolk VA, Chesapeake VA, Virginia Beach VA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07392892

Phase 2, Phase 3, Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Norfolk VA, Fairfax VA, Durham NC, Columbia MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Fairfax VA, Silver Spring MD, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase 2, Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: Norfolk VA, Chesapeake VA, Virginia Beach VA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Norfolk VA, Silver Spring MD, Allentown PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase 2, Phase 3, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Norfolk VA, Durham NC, Hackensack NJ, Buffalo NY,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

for
Colorectal Cancer
Location: Norfolk VA, Salem VA, Philadelphia PA, Columbus OH,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT06948448

Phase 2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Norfolk VA, Midlothian VA, Charlottesville VA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Norfolk VA, Fairfax VA, Laurel MD, Winchester VA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase 2, Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for
Endometrial Cancer
Location: Norfolk VA, Washington D.C. DC, Willow Grove PA,
Sponsor: BioNTech SE

Sex: Female

Age: 18+

Code: NCT06340568

Phase 3, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Norfolk VA, Fairfax VA, Washington D.C. DC,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase 3, Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Norfolk VA, Newark DE, New York NY, Fairfield OH,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Norfolk VA, Chapel Hill NC, Columbus OH, Nashville TN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase 2, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Norfolk VA, Washington D.C. DC, Philadelphia PA,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase 2, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Norfolk VA, Fairfax VA, Wytheville VA, New York NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase 3, Recruiting